Bulletin
Investor Alert

New York Markets Close in:

Cerevel Therapeutics Holdings Inc.

NAS: CERE

GO
/marketstate/country/us

Countdown to close

/zigman2/quotes/218887907/composite

$

32.72

Change

+0.72 +2.23%

Volume

Volume 710,419

Aug 17, 2022, 3:16 p.m.

Real time quotes

/zigman2/quotes/218887907/composite

Previous close

$ 32.00

$ 32.72

Change

+0.72 +2.23%

Day low

Day high

$31.76

$33.37

Open
Open: 31.92

52 week low

52 week high

$19.86

$46.16

Open

Market cap

$4.98B

Average volume

824,245

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-1.90

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/cere

MarketWatch News on CERE

  1. Cerevel Therapeutics started at neutral with $30 stock price target at Mizuho

    7:06 a.m. July 7, 2022

    - Tomi Kilgore

  2. Cerevel Therapeutics started at overweight with $50 stock price target at J.P. Morgan

    8:15 a.m. Jan. 5, 2022

    - Tomi Kilgore

  3. Cerevel Therapeutics stock price target raised to $33 from $21 at Stifel Nicolaus

    7:10 a.m. July 13, 2021

    - Tomi Kilgore

  4. Cerevel Test Data Scrambles Schizophrenia Stocks

    8:19 a.m. June 30, 2021

    - Barron's Online

  5. 7 hard lessons for investors from the DoorDash and Airbnb IPOs

    10:26 a.m. Dec. 19, 2020

    - Michael Brush

  6. Cerevel Therapeutics started at buy with $17 stock price target at Stifel Nicolaus

    10:31 a.m. Nov. 9, 2020

    - Tomi Kilgore

/news/nonmarketwatch/company/us/cere

Other News on CERE

  1. Karuna Therapeutics Shareholders Hit the Jackpot

    2:27 p.m. Aug. 11, 2022

    - GuruFocus.com

  2. BBBY, SUNW and MYOV are among pre market gainers

    8:33 a.m. Aug. 8, 2022

    - Seeking Alpha

  3. Warning: CERE is at high risk of performing badly

    4:59 a.m. Aug. 2, 2022

    - Seeking Alpha

  4. 10-Q: CEREVEL THERAPEUTICS HOLDINGS, INC.

    4:12 p.m. Aug. 1, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  5. Karuna Therapeutics: Front-Running KarXT Phase 3

    9:40 a.m. June 26, 2022

    - Seeking Alpha

  6. 10-Q: CEREVEL THERAPEUTICS HOLDINGS, INC.

    6:51 a.m. May 10, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  7. Cerevel Therapeutics GAAP EPS of -$0.46

    6:34 a.m. May 10, 2022

    - Seeking Alpha

  8. 10-K: CEREVEL THERAPEUTICS HOLDINGS, INC.

    5:43 p.m. March 1, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  9. Cerevel Therapeutics GAAP EPS of -$0.40

    7:33 a.m. March 1, 2022

    - Seeking Alpha

  10. Neurocrine Biosciences Looking At A Year Of Heavy Lifting

    5:11 p.m. Feb. 15, 2022

    - Seeking Alpha

  11. Loading more headlines...
/news/pressrelease/company/us/cere

Press Releases on CERE

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.